IAG Strategic Imaging for Accelerated Drug Development
Por um escritor misterioso
Descrição
Imaging as a Tool to Accelerate Drug Development & Lower the Risk of Biotech Investment
NEURO-MUSCULAR DISORDERS
Cancers, Free Full-Text
Lucid Scientific Secures $7 Million Series A Financing Led by IAG Capital Partners
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies - The Lancet
Molecules, Free Full-Text
Immuno-Oncology Drug Development
IAG Strategic Imaging for Accelerated Drug Development
Clinical Trial
de
por adulto (o preço varia de acordo com o tamanho do grupo)
